Physicians and Pharmaceutical Industry

Relationships between academic medical institutions as well as individual physicians have been vigorously debated in media and within the medical society during last years. Recently, European Federation of Internal Medicine, the ACP-ASIM Foundation, and the ABIM Foundation have developed a “physician’s charter” a sort of contemporary Hippocrates’s oath, to encompass a set of principles to which all medical professionals can and should aspire (1).

Keywords: Organ Transplantation, pharmaceutical industry, Clinical Trials